A slowdown in the Chinese economy along with escalating tensions in Ukraine sent the markets tumbling to a sharply lower close with the Dow collapsing 231 points to 16,108. Nasdaq plummeted 62 points to 4260.
On the upside
Scientific Games (Nasdaq: SGMS) narrowed fourth quarter losses more than expected as revenue soared.
Chelsea Therapeutics (Nasdaq: CHTP) widened fourth quarter losses but with the recent approval of Northera, Wedbush expects the company to be an attractive acquisition target.
Unilife (Nasdaq: UNIS) entered a $60 million debt financing agreement with OrbiMed.
On the downside
Covisint (Nasdaq: COVS) reported preliminary fourth quarter revenue below analyst expectations.
Discovery Laboratories (Nasdaq: DSCO) widened fourth quarter losses.
The Consumer Financial Protection Bureau opened an inquiry into World Acceptance (Nasdaq: WRLD) for possible violations of consumer protection laws.
In the broad market, declining issues outpaced advancers by a margin of more than 2 to 1 on the NYSE and by nearly 7 to 2 on Nasdaq. The broader S&P 500 plunged 21 points to 1846. Bitcoin lost $4.09 or 0.64% to $633.88.
